Search results
Results from the WOW.Com Content Network
Women can transmit the HIV/AIDS virus to other women through sexual intercourse. [14] However, the U.S. does not statistically categorize HIV/AIDS transmission in forms other than heterosexual, intravenous drug, or indefinable transmission. [3] Due to lack of research, statistics on women-to-women transmission of HIV is unknown. [15]
Women with HIV have been shown to have decreased fertility which can affect available reproductive options. [119] In cases where the woman is HIV negative and the man is HIV positive, the primary assisted reproductive method used to prevent HIV transmission is sperm washing followed by intrauterine insemination (IUI) or in vitro fertilization ...
TDF alone can be offered to heterosexual men and women where FTC is contraindicated. PrEP is not recommended for people who inject drugs where needle exchange and opiate substitution programs are available and accessed by the individual. PrEP with daily oral TD-FTC for HIV-negative trans women who are at risk of HIV acquisition through ...
“It helps give men options tailored to their lifestyles, especially for those who find a daily pill challenging,” says Dr. Ratevosian. ... you can manage HIV like diabetes, high blood pressure ...
(Reuters) -Gilead Sciences said on Thursday a late-stage study showed its long-acting injectable drug was more effective in preventing HIV infection in women compared to its existing daily pill ...
Heterosexual men or women who do not regularly use condoms during sex with partners of unknown HIV status who are substantial risk; Injection of drugs in the last six months with sharing of equipment; Serodiscordant heterosexual and homosexual partners, where one partner is HIV-positive and the other HIV-negative
Strong sales of medicines for HIV, the virus that causes AIDS, were one of the drivers behind the company's performance last year, generating 6.44 billion pounds ($8.13 billion) in annual sales.
The HIV Prevention Trials Network conducted a clinical trial, HPTN 052, that analyzed the effectiveness of antiretroviral drugs on the HIV-1 virus. 1,783 HIV sero-discordant couples, or couples that consist of an HIV-positive individual and an HIV-negative partner, from nine different countries were a part of the study, 97% of the couples being ...